Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)Study completedNCT00005832
What this trial is testing

S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network 58
Testing effectiveness (Phase 2)Study completedNCT01543412
What this trial is testing

Second Line Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Testing effectiveness (Phase 2)Active Not RecruitingNCT05915351
What this trial is testing

Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreas AdenocarcinomaPancreas Cancer
University of Kansas Medical Center 28
Testing effectiveness (Phase 2)Looking for participantsNCT06491472
What this trial is testing

Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Early research (Phase 1)Study completedNCT01342224
What this trial is testing

Immunochemoradiotherapy in Patients With Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
Providence Health & Services 11
Testing effectiveness (Phase 2)Looking for participantsNCT06453486
What this trial is testing

High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
University Health Network, Toronto 43
Testing effectiveness (Phase 2)Looking for participantsNCT07589569
What this trial is testing

An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shandong Suncadia Medicine Co., Ltd. 92
Testing effectiveness (Phase 2)Study completedNCT01523457
What this trial is testing

Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic Cancer
Yale University 75
Not applicableStudy completedNCT03614910
What this trial is testing

Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System

Who this might be right for
Pancreatic Cancer
Holy Name Medical Center, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06008288
What this trial is testing

A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.

Who this might be right for
KRAS P.G12CPancreatic CancerSolid Tumor
Allist Pharmaceuticals, Inc. 88
Early research (Phase 1)Ended earlyNCT03878524
What this trial is testing

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAnatomic Stage IV Breast Cancer AJCC v8Anemia+47 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07208539
What this trial is testing

AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
Shanghai Zhongshan Hospital 77
Early research (Phase 1)Study completedNCT00836407
What this trial is testing

Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Testing effectiveness (Phase 2)UnknownNCT02635971
What this trial is testing

Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic
Fudan University 168
Testing effectiveness (Phase 2)Study completedNCT01959672
What this trial is testing

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaResectable Pancreatic CarcinomaStage I Pancreatic Cancer+6 more
University of Nebraska 11
Not applicableWithdrawnNCT05360745
What this trial is testing

Quality of Life With Nutritional Supplementation in Patients With Locally Advanced/Metastatic Pancreatic Cancer.

Who this might be right for
Quality of LifeLocally Advanced Pancreatic CarcinomaMetastatic Pancreatic Cancer
Fundacion para la Excelencia y la Calidad de la Oncologia
Testing effectiveness (Phase 2)UnknownNCT06353581
What this trial is testing

Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Yonsei University 78
Not applicableStudy completedNCT00448838
What this trial is testing

Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Miami 42
Next Page